Skip to main content
logo
Bio Solution Co.,Ltd. (KOSDAQ:086820)
South Korea flag South Korea · Delayed Price · Currency is KRW
6,200.00
-180.00 (-2.82%)
At close: Jul 28, 2026

Bio Solution Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2020FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '20 Dec '19
Revenue
15,82415,20012,8897,7448,882
Revenue Growth
22.77%17.93%66.43%-12.81%-
Gross Profit
9,9839,5688,1284,2465,850
Operating Income
-4,262-4,341-5,069-3,330-1,868
Net Income
654.91273.36-11,928-1,800-697.54
Earnings Per Share
27.0111.32-496.00-75.33-29.67
EPS Growth
-----

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2020FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '20 Dec '19
Cash & Investments
11,21212,09414,35036,20440,480
Total Debt
19,48230,91131,4901,434761.4
Net Cash (Debt)
-8,270-18,817-17,14034,77039,718
Net Cash Growth
----12.46%-
Net Cash Per Share
-341.12-778.97-712.721455.341683.89

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2020FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '20 Dec '19
Operating Cash Flow
-1,222-1,312-2,286-1,686-2,606
Capital Expenditures
-240.6-184.98-379.79-1,391-2,179
Free Cash Flow
-1,462-1,497-2,666-3,077-4,785
Free Cash Flow Growth
-----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2020FY 2019
Period EndingMar '26 Dec '25 Dec '24 Dec '20 Dec '19
Gross Margin
63.09%62.95%63.06%54.83%65.86%
Operating Margin
-26.94%-28.56%-39.33%-43.00%-21.03%
Pretax Margin
4.14%1.80%-92.55%-23.24%-7.85%
Profit Margin
4.14%1.80%-92.55%-23.24%-7.85%
FCF Margin
-9.24%-9.85%-20.69%-39.73%-53.87%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2020FY 2019
Period EndingJul '26 Dec '25 Dec '24 Dec '20 Dec '19
PE Ratio
229.53699.46---
PS Ratio
10.1112.5813.3930.3238.50